| Inhibitory immune checkpoint receptors and ligands as prognostic biomarkers in COVID-19 patients MA Al-Mterin, A Alsalman, E Elkord Frontiers in immunology 13, 870283, 2022 | 17 | 2022 |
| Immunotherapy or targeted therapy as the first-line strategies for unresectable hepatocellular carcinoma: a network meta-analysis and cost-effectiveness analysis K Liu, Y Zhu, H Zhu Frontiers in Immunology 13, 1103055, 2023 | 12 | 2023 |
| Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal … A Alsalman, MA Al-Mterin, K Murshed, F Alloush, ST Al-Shouli, SM Toor, ... Cancers 14 (13), 3194, 2022 | 11 | 2022 |
| Associations of different immune checkpoints-expressing CD4+ Treg/ T cell subsets with disease-free survival in colorectal cancer patients MA Al-Mterin, K Murshed, A Alsalman, A Abu-Dayeh, E Elkord BMC cancer 22 (1), 601, 2022 | 9 | 2022 |
| Role of T regulatory cells and myeloid-derived suppressor cells in COVID-19 A Alsalman, MA Al-Mterin, E Elkord Journal of immunology research 2022, 2022 | 9 | 2022 |
| Chromatographic Analysis (LC-MS and GC-MS), Antioxidant activity, total phenol and total flavonoid determination of Ononis natrix L. grown in Jordan MA Al-Mterin, NH Aboalhaija, IF Abaza, MH Kailani, MA Zihlif, FU Afifi Jordan Journal of Chemistry (JJC) 16 (1), 31-39, 2021 | 8 | 2021 |
| Associations of complete blood count parameters with disease-free survival in right-and left-sided colorectal cancer patients A Alsalman, MA Al-Mterin, A Abu-Dayeh, F Alloush, K Murshed, E Elkord Journal of personalized medicine 12 (5), 816, 2022 | 6 | 2022 |
| PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naive CRC patients MA Al-Mterin, K Murshed, E Elkord Cancer Immunology, Immunotherapy 72 (6), 1933-1939, 2023 | 4 | 2023 |
| Correlations between Circulating and Tumor-Infiltrating CD4+ Treg Subsets with Immune Checkpoints in Colorectal Cancer Patients with Early and Advanced Stages MA Al-Mterin, K Murshed, E Elkord Vaccines 10 (9), 1471, 2022 | 4 | 2022 |
| Correlations between Circulating and Tumor-Infiltrating CD4+ T Cell Subsets with Immune Checkpoints in Colorectal Cancer MA Al-Mterin, K Murshed, E Elkord Vaccines 10 (4), 538, 2022 | 4 | 2022 |
| Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets MA Al-Mterin, E Elkord Exploration of targeted anti-tumor therapy 3 (4), 497, 2022 | 4 | 2022 |
| Effects of Ononis natrix on glucose and lipid metabolism: An in vivo study. MA AL-MTERIN, N ABOALHAIJA, MA ZIHLIF, FU AFIFI Journal of Research in Pharmacy 28 (1), 2024 | | 2024 |
| Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8+ T cells showed synergistic effects on improved disease-free survival in treatment-naïve CRC patients A Meyiah, GM Chalbatani, MA Al-Mterin, MA Malekraeisi, K Murshed, ... International Immunopharmacology 119, 110207, 2023 | | 2023 |
| Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation Y Xu, Q Li, J Zhao, X Ni, P Li, W Hu Frontiers in Immunology 13, 1064488, 2022 | | 2022 |
| Circulating and Tumor-Infiltrating Immune Checkpoints-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients … A Alsalman, MA Al-Mterin, K Murshed, F Alloush, ST Al-Shouli, SM Toor, ... s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | | 2022 |
Eyad ElkordProfessor of Immunology, XJTLU, Suzhou & Honorary Professor, University of Salford, ManchesterΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα salford.ac.uk
